by Admin | October 16, 2014 12:40 pm
October 16, 2014—The Health Resources and Services Administration has told an undetermined number of orphan drug manufacturers that they are out of compliance with 340B statutory requirements and their pricing agreements with the government and must notify it of their plans to repay affected rural and freestanding cancer hospitals for overcharges. It is HRSA’s most significant enforcement action affecting drug manufacturers in the 340B program’s 22-year history.
Source URL: https://340binformed.org/2014/10/hrsa-tells-drugmakers-to-repay-hospitals-for-340b-orphan-drug-overcharges/
Copyright ©2022 340binformed.org unless otherwise noted.